{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042406","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.088351+00:00","generated_at":"2026-05-30T10:38:02.686991+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Calidi Biotherapeutics raises $2M in registered direct offering and private placement of warrants","bullets":["Sold 2,050,000 shares at $1.00 per share in a registered direct offering.","Concurrent private placement: Series E and F warrants to purchase up to 2,050,000 shares each at $1.13, exercisable after 6 months.","Gross proceeds ~$2 million; net proceeds for working capital and clinical trials.","Placement agent Ladenburg Thalmann receives 8% cash fee and warrants for 102,500 shares at $1.25.","Lock-up agreements: Company 30 days, directors/officers 90 days from closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042406","json":"https://secwatch.observer/filing/0001493152-24-042406.json","markdown":"https://secwatch.observer/filing/0001493152-24-042406.md","text":"https://secwatch.observer/filing/0001493152-24-042406.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224042406/0001493152-24-042406-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224042406/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:38:02.686991+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}